Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
SOC Telemed, the nation’s largest national provider of telemedicine technology to healthcare providers, has acquired behavioral health telemedicine company JSA Health.
Never has so much data been available—but those in medicine face the ongoing challenge of making the most of what’s available. A new report from Deloitte examined just how medical technology companies can improve outcomes, reduce costs and bolster efficiency.
Seattle, Boston, Atlanta, New York and Columbus, Ohio, are just a handful of cities seeing hospitals enter the real estate space in a community-based approach to healthcare, NPR reported.
A team of Australian researchers found those who consulted online resources had better interactions, because it led to more informed discussions while not undermining trust in diagnoses and treatment plans. Still, while the activity was generally considered positive, searches could increase patient anxiety.
BrainsWay recently received de novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for treating obsessive compulsive disorder (OCD) in adults.
As the debate around rising drug prices heightens, pharmacy benefit managers are taking on more scrutiny over copays that are sometimes higher than buying the drug out of pocket.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.